AMAG Pharmaceuticals Inc (AMAG) - Medical Equipment - Deals and Alliances Profile

AMAG Pharmaceuticals Inc (AMAG) - Medical Equipment - Deals and Alliances Profile


  • Products Id :- GDME3552D
  • |
  • Pages: 52
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

AMAG Pharmaceuticals Inc (AMAG) develops and commercializes specialty pharmaceutical products with focus on maternal health, anemia management and cancer supportive care. It develops and markets products used to reduce the risk of preterm birth in women with a single baby who have a history of singleton spontaneous preterm birth; and products for the treatment of iron deficiency anemia (IDA) in adult patients who have intolerance to oral iron and chronic kidney diseases. AMAG also provides services related to the collection, processing and storage of umbilical cord blood stem cell and cord tissue units. The company offers its products through a direct sales force and a network of distributors. AMAG is headquartered in Waltham, Massachusetts, the US.

AMAG Pharmaceuticals Inc (AMAG)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

AMAG Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

AMAG Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

AMAG Pharmaceuticals Inc, Medical Equipment, Deal Details 10

Private Equity 10

GI Partners Acquires CBR Systems from AMAG Pharma for USD530 Million 10

Access Pharma Enters Into Licensing Agreement With Amag Pharma For MuGard 12

Equity Offering 13

AMAG Pharma Raises USD230.9 Million in Public Offering of Shares 13

Amag Pharma Files Registration Statement For Public Offering Of Securities For Up To USD 250 Million 15

Debt Offering 16

AMAG Pharma Prices Public Offering of 3.25% Notes Due 2022 for USD300 Million 16

AMAG Pharma Raises USD500 Million in Private Placement of 7.878% Notes Due 2023 18

Amag Pharma Completes Public Offering Of Notes Due 2019 For USD 200 Million 19

AMAG Pharmaceuticals Inc-Key Competitors 21

AMAG Pharmaceuticals Inc-Key Employees 22

AMAG Pharmaceuticals Inc-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 24

Financial Announcements 24

Aug 02, 2018: AMAG Pharmaceuticals announces second quarter 2018 financial results and provides corporate update 24

May 03, 2018: AMAG Pharmaceuticals Announces First Quarter 2018 Financial Results and Raises Full Year Financial Guidance 26

Feb 27, 2018: AMAG Reports 2017 Financial Results and Company Update 28

Jan 08, 2018: AMAG Pharmaceuticals Announces Preliminary 2017 Financial Results and Provides 2018 Guidance 30

Nov 02, 2017: AMAG Pharmaceuticals Announces Third Quarter 2017 Financial Results and Business Highlights 32

Aug 03, 2017: AMAG Pharmaceuticals Announces Second Quarter 2017 Financial Results and Provides Corporate Update 35

May 02, 2017: AMAG Pharmaceuticals Announces First Quarter 2017 Financial Results and Provides Corporate Update 39

Feb 14, 2017: AMAG Reports Fourth Quarter and Full Year 2016 Financial Results 41

Jan 09, 2017: AMAG Pharmaceuticals Provides Financial and Business Update 44

Corporate Communications 46

Aug 06, 2018: AMAG Pharmaceuticals Appoints Brian Robinson, M.D. as Senior Vice President of Medical Affairs 46

May 02, 2018: AMAG Pharmaceuticals Appoints J. Alan Butcher as Executive Vice President and Chief Business Officer 47

Aug 08, 2017: AMAG Pharmaceuticals Appoints Oscar Sanchez as Vice President of Quality 48

May 16, 2017: AMAG Pharmaceuticals Appoints Helen Milton, Ph.D. as Vice President of Regulatory Affairs 49

Apr 25, 2017: AMAG Pharmaceuticals Appoints Arpad Simon, M.D. as Vice President of Pharmacovigilance 50

Mar 06, 2017: AMAG Announces Management Changes and New Commercial Appointments 51

Appendix 52

Methodology 52

About GlobalData 52

Contact Us 52

Disclaimer 52

List of Figures

AMAG Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

AMAG Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

AMAG Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

List of Tables

AMAG Pharmaceuticals Inc, Medical Equipment, Key Facts, 2017 2

AMAG Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

AMAG Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

AMAG Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8

AMAG Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

GI Partners Acquires CBR Systems from AMAG Pharma for USD530 Million 10

Access Pharma Enters Into Licensing Agreement With Amag Pharma For MuGard 12

AMAG Pharma Raises USD230.9 Million in Public Offering of Shares 13

Amag Pharma Files Registration Statement For Public Offering Of Securities For Up To USD 250 Million 15

AMAG Pharma Prices Public Offering of 3.25% Notes Due 2022 for USD300 Million 16

AMAG Pharma Raises USD500 Million in Private Placement of 7.878% Notes Due 2023 18

Amag Pharma Completes Public Offering Of Notes Due 2019 For USD 200 Million 19

AMAG Pharmaceuticals Inc, Key Competitors 21

AMAG Pharmaceuticals Inc, Key Employees 22

AMAG Pharmaceuticals Inc, Other Locations 23

AMAG Pharmaceuticals Inc, Subsidiaries 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

AMAG Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17958
Site License
USD 500 INR 35915
Corporate User License
USD 750 INR 53873

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com